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Abstract 
This discussion highlights ethical and practical issues potential neuropsychologist-imagers should 
consider in conducting functional magnetic resonance imaging (fMRI). While fMRI is not currently 
approved for clinical use, research is ongoing which has implications for clinical practice, from refining 
brain–behavior relationships, to assisting with diagnosis and treatment decisions. To protect the welfare 
of cognitively impaired populations requires special care with respect to MR risks and informed consent. 
Competent functional imaging requires an understanding of the strengths, limitations, and appropriate 
domain of applications of the measure. 
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1. Introduction 
Functional MRI (fMRI) has great potential to enhance the characterization of brain 
integrity in people with cognitive dysfunction; hence, neuropsychologists have joined the 
rush to use this technology. This fact was strikingly evident at the 2002 International 
Neuropsychology Society meetings where 60 percent of the symposia revolved around 
brain imaging. Functional MRI is becoming more widely applied in part because it is 
noninvasive, can be performed in sites with clinical MRI’s, and there are easily available, 
affordable, analysis tools. While fMRI is not yet approved for clinical use, techniques are 
being tested and validated which have the potential to become part of the tools of the 
neuropsychologist. Guidelines for use must thus follow both from the specific constraints 
of the MRI technology and the domains of appropriate application. While detailed 
descriptions of guidelines for the ethical and competent practice of clinical 
neuropsychology, psychological assessment, and test use have been described (American 
Academy of Neurology, 1996; American Psychological Association, 1992; Turner, 
DeMers, Fox, & Reed, 2001), these do not adequately cover the specific requirements 
and potential applications presented by fMRI. Below are suggested revisions of these 
standards.  
The focus of this paper will be on aspirational goals for the manner in which fMRI data 
may be ethically applied to the practice of clinical neuropsychology; however, many of 
the recommendations are relevant to all fMRI users. The first section discusses informed 
consent for the procedure and risks. The second section outlines a series of core 
competences. For example, fMRI imagers must understand the kinds of questions that 
can be interrogated with the technique and they must cope with threats to validity, 
limitations on generalizability, and avoid analysis and interpretive errors. The final 
section briefly discusses examples of clinical applications and related ethical problems.  
2. Informed consent, competence, and protection from 
harm 
There are several protections for patients with cognitive impairments who participate in 
medical research. These issues are discussed in more detail elsewhere (Dunn & 
Chadwick, 1999) but will be briefly summarized below. The right of individuals to 
choose what will happen to them would likely prevail in a situation, such as deciding not 
to perform functional imaging, where there is no clear benefit from undergoing the 
procedure ( National Commission for the Protection of Human Subjects of Biomedical & 
Behavioral Research, 1979). Even when there are approved clinical uses, the level of 
benefit to the patient and the existence of alternative procedures to address the clinical 
needs must be weighed against the risks of the procedure. Under no circumstances should 
anyone be allowed to participate in an fMRI study if there are significant safety concerns, 
even if they acknowledge and wish to participate in spite of the risks. During the process 
of obtaining informed consent, participants need to be provided with adequate 
information regarding planned procedures which they must comprehend and voluntarily 
agree to without undue coercion (for a clear discussion see Dunn et al., 1999; National 
Commission for the Protection of Human Subjects of Biomedical & Behavioral Research, 
1978; NBAC, 1998). Information typically important to include are the specific benefits 
to the individual or to patient care in general, risks, right to withdraw from participation, 
and to have questions answered. Procedures must be adapted to patients to compensate 
for cognitive deficits that interfere with comprehension, requests for information, or 
memory for information that would affect the patient’s willingness to participate. A 
signature on a consent form is evidence that this process was completed successfully.  
There are some special issues to consider with respect to informed consent and the MRI 
environment. In informing patients of potential risks, it is important for an imager to 
assess each patient carefully with respect to their risk in the MRI environment and to 
consult more expert colleagues, typically clinical radiologists, when there is any 
uncertainty. The most dangerous risks are from ferromagnetic objects which become 
projectiles in the strong magnetic field of the MR scanner, and from implanted 
electromechanical devices, such as pacemakers, that cannot function in the magnetic 
field. Sometimes a neuroradiologist will request an X-ray as part of a safety evaluation 
and patients must also provide informed consent for this procedure. When there is a 
question as to whether a patient is an accurate reporter of his medical history due to 
cognitive impairments, at a minimum, special precautions such as a medical record 
review or a careful interview with a spouse should be instituted. Shellock offers 
comprehensive reference materials on the subject both in published form (Shellock, 2001;
Shellock, 2002) and on-line (www.mrisafety.com). Great caution should be exercised 
when studying people from certain occupations, particularly those involving grinding 
metal. If there is any concern that metal flakes entered the eyes, they should not be 
studied unless there is a compelling clinical need, and then only after a special workup 
(e.g., X-ray).  
Other typical safety issues include the necessity for all people, including any caregiver 
accompanying the patient in the MRI room, to wear MR compatible earplugs to dampen 
noise. There is also the potential for sensory stimulation, minor muscle twitches, 
particularly at higher field strengths than the standard clinical 1.5 Tesla MRI. There are 
no known residual health problems that result from these symptoms. Scanning 
claustrophobic people is problematic since the MRI environment is confining. Most 
people with claustrophobia will warn the investigator and probably choose to avoid the 
study, in which case of course they should neither be coerced nor even cajoled. Quite a 
few individuals with claustrophobia, however, even among those who volunteer as 
healthy participants, are unaware of their condition or decide to try to overcome it by 
forcing themselves into anxiety provoking situations. A good practice is to warn every 
potential participant. An example of such a warning might be "We previously asked you 
if you were uncomfortable in confined places such as elevators. Most of us are a little 
nervous the first time we undergo an MRI; however, occasionally people are surprised by 
how anxious they become and would like to end the study. Please tell us immediately if 
this is the case by pressing this alarm button and we will stop everything and promptly 
pull you out of the MRI." Participants typically need a great deal of reassurance and 
support if this occurs. Commonly participants fear disappointing the investigator or that 
they have a newly discovered anxiety disorder. Stressing that nervousness is natural and 
that "toughing it out" despite extreme anxiety invalidates the study often facilitates 
admissions of reluctance to continue participation.  
With respect to confidentiality, investigators in the behavioral sciences, where some 
disorders are still stigmatized, should be particularly vigilant with respect to whether their 
image files contain information that can identify patients. While there are no procedures 
available to identify uniquely someone on the basis of a picture of their brain, some 
image formats contain names if they were entered during data acquisition. It is possible to 
strip this information from the image files, however. This must be done if an investigator 
plans to provide data to larger databases such as the Neuroimaging Informatics 
Technology Initiative, or contribute to journals where there is the requirement to provide 
raw data (e.g., Journal of Cognitive Neuroscience). Several participants enter studies 
because they expect that their images will be reviewed by a physician. It is prudent to 
inform the participant whether or not this is the case during informed consent and to have 
in place a protocol for consulting with competent neuroradiologists in a situation where 
pathology is suspected. It is better yet to include a neuroradiologist who will routinely 
inspect the images and perform a "clinical reading" to the limited extent feasible from the 
structural component of the fMRI study. Regardless, it would be prudent to inform the 
participant that the fMRI procedure is not designed to screen for brain disorders and that 
if they suspect a problem they should consult a neurologist for referral to a clinical study. 
Of course, neuropsychologists are not competent to practice neuroradiology and need to 
inform participants about this limitation. If neuropsychologists detect an abnormality on 
an MRI scan, they should consult a neuroradiologist to decide whether a clinical referral 
should be made. Ethical issues associated with such incidental findings are discussed 
elsewhere (Illes, Desmond, Huang, Raffin, & Atlas, 2002; Kulynych, 2002).  
Like other clinical investigators, functional imagers may confront situations where 
decisions must be carefully made as to whether a patient is competent to consent to 
undergo functional imaging. Obtaining informed consent from the cognitively intact 
participants themselves is the rule, but questions of competence to consent may arise with 
several populations such as children, retarded individuals, people with certain 
neuropsychiatric disorders or otherwise cognitively impaired patients. If there is a 
question as to whether the patient is capable of formal informed consent, it is possible to 
include a surrogate or proxy decision maker and to obtain the patient’s assent. A person is 
capable of assent if they know the procedures they will undergo, unambiguously 
communicate this willingness to participate, and understand their right to withdraw from 
participation at any time (National Commission for the Protection of Human Subjects of 
Biomedical & Behavioral Research, 1978). Establishing that the patient can provide a 
reliable yes-no response is crucial (e.g., asking redundant questions with different 
responses "Do you want to stop? Do you want to continue?"). It is the recommendation of 
the National Bioethics Advisory Commission ( NBAC, 2001) that assent alone is not 
sufficient to enroll a patient in a research protocol. The role of the proxy decision maker 
is to advise the investigator how the patient would have decided had he or she been 
cognitively capable. This topic is reviewed in depth elsewhere (Dunn et al., 1999; NBAC, 
1998; NBAC, 2001).  
The MRI environment imposes particular difficulties for investigators in monitoring 
patient’s continued willingness to participate. Patients lie in the MRI so that many cues 
about their emotional status, such as their facial expressions, are not observable. It is thus 
crucial to assess carefully whether it is possible, and what kind of support patients need in 
order to remain motivated and oriented to the task at hand. For example, patients with 
severe memory disorders need to be repeatedly monitored since they are vulnerable to 
disorientation. Furthermore, it is important to be vigilant for cues that indicate the 
patient’s willingness to continue has changed. For example, some patients are surprised 
to discover they have become claustrophobic in the MRI environment and might begin to 
try to escape from a head positioning device. It is advisable to agree ahead of time on a 
signal for distress, but it may be necessary to incorporate breaks and ask through the 
intercom or headphones whether the participant feels comfortable continuing the study.  
3. General core competence in the use of fMRI 
measures 
Most neuropsychological practice and potential applications of fMRI fall within the 
domain of assessment. Given the costs of using the MRI, fMRI is not likely to be used 
directly in therapy in the near future. Guidelines for test user qualifications for 
psychologists specify necessary general and domain specific knowledge and skills 
(Turner et al., 2001). This section focuses on general problems with which an fMRI user 
must cope. The next section will briefly outline examples of clinical translations and the 
manner in which ethical issues are relevant.  
Current ethical guidelines dictate that psychologists not practice outside limits of their 
education, training, and experience. Because there are no FDA approved clinical uses for 
fMRI, credentials and training requirements have not been established. This situation will 
likely change as clinical applications are tested and validated (for excellent reviews on 
fMRI task design, see Aguirre & D’Esposito, 2000; Donaldson & Buckner, 2002; Miezin, 
Maccotta, Ollinger, Petersen, & Buckner, 2000). There are minimal and crucial skills to 
be acquired and knowledge that must be learned to assure valid fMRI results and these 
are not formally taught to psychologists as part of their training. Until there are 
significant technical advances, the burden is on the fMRI user to avoid confusing the 
scientific community with erroneous interpretations of artifacts. Below, there is a brief 
description of some of the major threats to valid fMRI results. For more detail, Thulborn 
and Gisbert (2002) provide a readable description of what is involved in actually 
acquiring fMRI data in a clinical setting.  
3.1. Selection and design of appropriate tests 
A central area of competence for developers of fMRI paradigms is understanding what 
questions can be addressed with the method, and keeping pace with advances in task 
design. Brain imaging studies are uninterpretable unless carefully designed and applied. 
It is tempting to create imaginative experiments that try to address clinically relevant 
questions directly such as "which brain structures underlie driving competence?", and to 
have patients performing simulated driving evaluations in an fMRI study. These studies 
of complex tasks will essentially activate the entire brain. For example, visual cortex will 
be activated by looking at the road, and motor cortex will become active when one turns 
a steering wheel. Neither of these findings is likely to yield anything surprising or 
distinctive about driving. Ultimately, one would need to establish predictive or criterion 
validity, in this case, predicting driving accidents. Unless the external event occurs 
frequently, one would need to image many people to have a large enough sample to 
establish a correlation. In part, because of the expense of imaging, these studies are 
difficult to perform. For these reasons, it is hard, but not necessarily impossible, to apply 
functional imaging in a manner that would justify making specific recommendations 
about complex tasks such as a given functional capacity. As with other 
neuropsychological tests, a functional imaging evaluation would need to be interpreted in 
a larger context of a comprehensive cognitive evaluation.  
In contrast, the underlying construct of a well-designed brain imaging paradigm is 
typically the definition of a single or network of brain structures subserving a specific 
cognitive process (e.g., Gur, Erwin, & Gur, 1992). Because fMRI analyses involve 
thousands of statistical comparisons (leading to a high likelihood of false positive 
results), an imager must have some a priori hypothesis about which specific brain 
structures are likely to be activated by the cognitive task. Hypotheses typically are 
developed from lesion studies in humans and animals, or from recordings from single 
neurons in which the human or animal is performing a behavior. While all tests must be 
interpreted within the context of a more comprehensive evaluation, fMRI is likely to be 
most valuable in situations where clinical decision making hinges on a limited number of 
brain functional systems.  
In this context it is important to remember that many of the functional imaging studies 
performed hitherto included small samples and their effects may have limited 
applicability to individual cases. Without better knowledge of how many individual 
participants are expected to show an effect, it is hazardous to conclude about an 
individual that the pattern of activation is "abnormal." It will take the field a while to 
assemble the kind of "normative" data that would permit individual assessments. The 
ethical neuropsychologist will be careful to avoid inappropriate and premature use of the 
power of fMRI to show effects that to a layman may seem conclusive but that in reality 
may reflect dubious procedures or interpretations. Nonetheless, the power of the method 
will eventually bring it to the clinical arena and those neuropsychologists who learn how 
to use fMRI competently and carefully will be poised to exploit its immense potential for 
assessment of disease and treatment effects.  
An example of how an fMRI finding can lead to pressures for premature application is 
recent studies showing the ability of fMRI to detect deception (Langleben et al., 2002). 
Attorneys, judges, and law enforcement agencies rushed to try and use fMRI for lie 
detection, not realizing that the effects were demonstrated on group data and the road is 
long before the method can be justified for identifying individual deceivers, let alone 
specific items in which deception has occurred. It is an ethical obligation of a 
neuropsychologist to explain these limitations to potential clients who may want to use 
the study in litigation or law enforcement.  
3.2. Sources of error variance 
3.2.1. Artifacts from acquisition and individual differences in the MRI signal 
A competent fMRI user is vigilant and aware of how to cope with acquisition artifacts, a 
major threat to the validity of imaging results. There are known artifacts at the level of 
image acquisition, such as signal loss (appearing as dark regions called susceptibility 
artifact). They are problematic in regions where tissue characteristics change abruptly, 
such as near air passages. Susceptibility artifacts abound near the orbitofrontal/anterior-
medial temporal region of the brain. Other artifacts include movement artifacts, field 
inhomogeneity effects ("shading"), physiological artifacts related to heart rate and 
breathing, anatomic distortions and other causes of instability of the fMRI signal. There 
are techniques under development such as "on-line" movement correction, acquiring 
separate images within the susceptibility region, and compensating for image distortions. 
Until corrections or detection algorithms become routine, imagers must be able to 
recognize these problems and determine in each patient whether they can be ameliorated 
through post-processing or careful interpretation.  
Aside from artifacts within an individual scan, fMRI researchers must be aware that there 
are differences across individuals and MRI sites, and scanner "drifts" within the same 
facility even within a single session, which introduce artifacts and error. Even if one 
follows the exact same imaging protocol, the MRI signal differs across individuals 
(Aguirre, Zarahn, & D’Esposito, 1998; Buckner, Snyder, Sanders, Raichle, & Morris, 
2000; D’Esposito, Zarahn, Aguirre, & Rypma, 1999). Statistical comparisons across 
different patient groups must take into account these individual differences. MRI 
manufacturers, and upgrades of the same manufacturer, may change the image quality of 
the MRI so there must be user intervention to test and compensate for changes in 
parameters such as image contrast and field homogeneity. Methods of testing 
comparability of data across different sites are under development for structural (e.g., 
Styner, Charles, Park, & Gerig, 2002) and functional (G. Glover, personal 
communication) imaging protocols. The process typically involves scanning a phantom 
or relatively stable test subject (e.g., a person without a progressive dementia or a 
developing brain) at several MRI sites and analyzing the inter- and intra-site stability of 
the measure of interest.  
Functional MRI investigators must also be familiar with artifacts that constrain processes 
that can be studied. For example, tasks that require overt verbal responses are not often 
studied with fMRI because of the associated head movement and susceptibility artifact 
from changes in the vocal cavity. In addition, it is difficult for the participant to hear 
auditory stimuli, or for the investigator to hear responses over the noise of the MRI, 
without special equipment. Some cognitive tasks that are part of a standard cognitive 
evaluation, such as confrontation naming, verbal fluency, and memory recall are thus 
problematic to study with fMRI. There are specialized image processing techniques to 
compensate for talking-related artifact in the MRI (e.g., Birn, Bandettini, Cox, & Shaker, 
1999), however, the burden is on the imager to demonstrate that activation is not 
artifactual.  
3.2.2. Inappropriate controls 
Functional MRI depends on differences between conditions and hence the choice of 
comparison tasks affects the sensitivity of the measure. Activation and control conditions 
are carefully matched for motor and sensory stimulation, as well as other hypothesized 
confounding cognitive processes. Often, a resting baseline (control) or a less carefully 
matched condition is included. The choice of baseline condition has been a subject of 
controversy (e.g., Stark & Squire, 2001) since, for example, if participants continue to 
rehearse mentally the experimental task, the difference in activation between task-on and 
task-off will be reduced. Ultimately, a competent imager must be familiar with the 
opinions in the field and able to defend how well the choice of comparison tasks controls 
for activations that are unrelated to the domain of interest.  
3.2.3. Standardized administration procedures 
While the standardized neuropsychological assessment rigidly adheres to carefully 
worded scripts and particular stimulus materials, and hence neuropsychologists are well 
trained in rigorous testing procedures, fMRI has additional requirements. Several of the 
problems of selecting appropriate control conditions are similar to those involved in 
standardization since one goal involves minimizing task-irrelevant brain activation. 
Imagers are responsible for monitoring the literature on processes invoked during 
imaging (e.g., sensory, motor, and rest) to increase the chance that appropriate 
standardization procedures will be instituted. For example, failure to standardize image 
contrast and visual angle generally has only subtle effects on neuropsychological tests. 
Variability in these and other perceptual and movement parameters has a large impact on 
brain activity because of differences such as amount of stimulation to visual cortex, eye 
movements, and spread of attention to the periphery. There are attempts to standardize 
the stimulus display and behavioral measurements in fMRI (e.g., Integrated Functional 
Imaging System, MRI Devices, Waukesha, WI); however, the costs are high and 
development is complex since MRI manufacturers build different sized MRI’s and 
stimulation paradigms vary considerably in their requirements.  
3.2.4. Characteristics of the test takers and generalizability 
Functional MRI users must be vigilant for motivational, cognitive, and functional 
disabilities which interfere with valid test performance. Not only is it unethical to 
perform fMRI on an unwilling patient, in most situations it is nearly impossible to obtain 
valid results. In some analyses, a head movement of greater than 2 mm over the course of 
a minute or an hour will render data useless. Investigators should aim to obtain on-line 
performance data and at least intermittently monitor the accuracy of behavioral responses 
during MRI scanning (typically there is a signal in the control room to the investigator, 
indicating the participant’s response). Such monitoring is needed to confirm that patients 
have not lost the instructional set or are responding intermittently. Paradigms that do not 
collect any measure of accuracy are problematic since one cannot be certain that patients 
are performing the desired cognitive operations.  
Certain aspects of the MRI environment make a task more cognitively complex than an 
evaluation outside the MRI. These nonspecific environmental effects may interact with 
certain forms of cognitive dysfunction. In addition to the constraints of the small space 
and complicated interaction between participant and investigator, there is a loud, 
distracting, radiofrequency pulse. Patients must often be able to remember and shift 
between different cognitive tasks based on cues or instructions given before the imaging 
task begins. Patients with severe memory or executive dysfunction may have difficulty 
remaining oriented or controlling the impulse to move. Patients may even fall asleep. All 
of these cognitive and motivational issues must be considered in interpreting data 
collected on patients in the MRI environment.  
Clinical assessments require compensation for disabilities that affect the validity of the 
measure; however, once the patient enters the MRI environment, changes to the paradigm 
in individual patients are ill advised unless the change in concomitant brain activity is 
part of the study. Furthermore, all items placed in the MRI environment have the 
potential for either producing artifact or being safety risks. For example hearing aids 
cannot be used. Acuity correction is not simple since most eye glasses contain metal and 
specially designed glasses need to be used. Sometimes investigators have every 
participant wear glasses, some with no correction, so that the periphery of the visual field 
is occluded equally in all participants.  
These practical and ethical problems, and difficulties with scanning unwilling or 
cognitively impaired patients, limit the population of patients that can undergo fMRI and 
hence the generalizability of findings. Essentially, fMRI will likely be restricted to mildly 
impaired patients until there are significant changes to the testing environment. This must 
be considered when one attempts to extrapolate findings to more cognitively and 
functionally impaired groups.  
3.2.5. Reliability and sensitivity 
A competent fMRI user is familiar with the particular statistical problems fMRI data 
raise; however, fMRI research is only beginning to address the quantification of 
reliability and measurement error. Imaging patients introduces another layer to this 
complex problem. New acquisition, experimental designs, and statistical analyses will 
likely be developed and optimized to address such concerns. Approaches to setting 
statistical thresholds are still heatedly debated in fMRI. Part of the reason is that task 
design markedly affects the sensitivity to activation. For example, an fMRI study that 
attempts to measure individual events (event-related fMRI) may demonstrate less robust 
results than one in which several events are averaged in a blocked design. On the other 
hand, event related fMRI could be particularly useful when comparing patients and 
controls since one can select only accurate trials across the groups (provided that the 
design has enough power for such an evaluation) and thus be more certain that the 
cognitive processes underlying the functional effects are similar. One could increase the 
number of trials to compensate for having a weaker ability to detect activation but then 
validity can be compromised by the ability of participants to tolerate the environment for 
a long period of time. Nonetheless, it is encouraging that studies examining reliability of 
fMRI results across different sites and within individuals have yielded promising results 
(Aguirre et al., 1998; Casey et al., 1998; Cohen & DuBois, 1999; Machielsen, Rombouts, 
Barkhof, Scheltens, & Witter, 2000; Ojemann et al., 1998; Rombouts, Barkhof, 
Hoogenraad, Sprenger, & Scheltens, 1998). The number of tasks in which reliability has 
been described, however, is quite small at present.  
3.3. Interpretation of results 
Conclusions about the role of a particular brain region in a cognitive process should be 
based on a convergence of information, not a given fMRI experiment. Functional MRI 
results are merely a statistical representation of a relationship between temporal changes 
in a cognitive task and recruitment of blood flow to a brain region. This co-occurrence 
does not definitively demonstrate that a brain region is involved in a task, only that the 
region may be active during the task. Even then, blood flow is only an indirect measure 
of neuronal activity. Because functional activation is defined based on statistical 
significance, failure to activate is a statistical null effect and should also be interpreted 
with great caution mindful of Type II error. Inappropriate control conditions and any of 
the above-described artifacts can reduce the chance of detecting an fMRI result or yield 
spurious findings. Neuropsychologists can provide crucial complimentary information to 
fMRI data as they are likely to be familiar with research demonstrating relationships 
between lesions and cognitive deficits that may suggest that the damaged area is 
necessary or provides connections to regions crucial for performance of a task. 
Performing fMRI on patients with brain dysfunction provides clues to the process of 
functional reorganization when effectiveness of recovery is associated with particular 
patterns of activation (e.g., Horwitz, Rumsey, & Donohue, 1998; Maguire, Vargha-
Khadem, & Mishkin, 2001).  
3.4. Consultation with colleagues and institutional support 
Because techniques are evolving quickly, it is recommended that anyone using fMRI in a 
program of research have significant institutional and expert collegial support. For 
example, sites should include a staff MR physicist who assures that the scanner performs 
to specifications and that data acquisition is maximally sensitive to functional activation. 
A physicist is also likely to understand and be familiar with artifacts that can disrupt 
image quality. Just as current, validated and sensitive tests should be used in the 
neuropsychological evaluation, there must be institutional support and adequate resources 
to pay for the MRI infrastructure, including software and hardware upgrades to MRI 
scanners. Special MR compatible equipment is needed for displaying stimuli and 
collecting behavioral data in the MRI and this poses difficult challenges. Sites should 
have access to engineers and machinists to develop and maintain such devices. Even 
experienced MR technicians need to be trained to avoid various artifacts that may distort 
the fMRI signal. For example, fMRI data are particularly vulnerable to artifacts from 
certain dental work or medications that affect blood flow and these are less of a problem 
for standard pulse sequences used in structural imaging for clinical purposes. Many sites 
have "image processors," people dedicated exclusively to image analysis and software 
development. Most investigators performing functional neuroimaging also obtain advice 
from software developers through on-line list servers. An imager must be competent to 
understand and evaluate the accuracy of this advice. This usually involves learning new 
approaches to statistical modeling and image processing and vigilant monitoring of new 
analysis techniques. Developers of research-dedicated image analysis products (e.g., 
AFNI, Statistical Parametric Mapping) recommend against clinical application because 
the source code is written by multiple users in the community and thus it is nearly 
impossible to guarantee it as error free. In its current implementation this software is far 
from "fool proof" and indeed not very "user friendly." Translating a paradigm from an 
experimental to a clinical application to be administered in multiple sites, as is done with 
neuropsychological tests, therefore requires much careful pre-testing and possibly 
debugging of computer code.  
4. Approaches to clinical translation 
There are several approaches the neuropsychologist might take to using data from fMRI. 
Potential clinical applications of fMRI are reviewed in more depth elsewhere (Detre & 
Floyd, 2001; Hammeke, 2002; Stern & Silbersweig, 2001; Thulborn et al., 2002). Ethical 
problems and dilemmas are omnipresent when translating research to clinical 
applications. In general, the more autonomy and flexibility fMRI users have, the greater 
the potential for error. Developing fMRI paradigms for potential clinical use in individual 
patients requires the highest level of skill and competence. Some day, there will likely be 
clinical protocols where both acquisition parameters and analyses have been well 
worked-out and established as valid and reliable across sites. Until such technical 
advances are achieved, fMRI users will still need to assess data quality and upgrade 
equipment and software. However, there will be less of a demand to innovate, as has been 
the case with the traditional clinical neuropsychological examination. Another approach 
to clinical application is using fMRI to validate other measures or techniques. For 
example, rather than applying fMRI to individual patients, one could study a subgroup of 
controls and validate new neuropsychological tests as indicators of the integrity of a 
particular brain system. Alternatively, one might use fMRI as a marker of drug treatment 
response in a patient group. In this form of clinical research, the burden on the researcher 
is to describe limitations to interpretation and generalizability. For example, careful 
description of the patients tested and methods by which areas of activation are defined is 
crucial for describing the manner in which a paradigm is applied. For instance, some 
investigators limit the number of statistical comparisons by a priori definition of a small 
brain region on the basis of structural landmarks. Some investigators interrogate a small, 
functionally defined, region of interest (e.g., using retinotopic mapping) before beginning 
a study. Most investigators perform analyses on the entire brain. Each of these 
approaches affects statistical power tremendously.  
4.1. Applications and ethical dilemmas 
Functional imaging may provide information about brain localization in individual 
patients that is unavailable with other technologies. For example, there is hope that fMRI 
can reveal islands of functional sparing within, and subtle functional decrements outside 
of lesions that are only grossly apparent on MRI scans. Interpreting lesion-function 
relations is confounded by the fact that there is functional reorganization after brain 
damage. Defining regions of brain activation with fMRI in individuals rather than on the 
basis of group studies further refines localization information. The fMRI study can 
describe the neural substrates of component processes of which behavioral 
neuropsychological tests detect only the result. For example, event related fMRI has not 
only separated the functional activation related to encoding from retrieval, but has also 
demonstrated differences in the same person in brain functioning during encoding of 
items that were remembered versus those that were forgotten (Brewer, Zhao, Desmond, 
Glover, & Gabrieli, 1998; Wagner et al., 1998). There are several important potential 
clinical fMRI applications that follow from these advantages.  
In neurosurgical interventions, accurate localization is critical and treatment risks are 
high. In the case of tumor removal or medial temporal lobe resection for seizure control, 
outcome can be improved (i.e., halting tissue destruction from invasive pathology or 
seizure control) as larger tissue volumes are removed; however, this must be balanced 
against the risk of damaging adjacent functionally active tissue. Localization errors can 
lead to significant disability and thus this application presents one of the highest levels of 
risk. Functional MRI can be applied to help the neurosurgeon walk this tightrope by 
identifying regions where there may be a greater risk of deficit following removal. Such 
paradigms can provide convergent data complementing information obtained by 
temporary inactivation techniques (e.g., Wada, TMS, or cortical stimulation during 
neurosurgery). Given the current state of technology, using fMRI alone without 
inactivation techniques is problematic.  
Just as structural imaging is central to the diagnosis of tumors and strokes, functional 
imaging is being tested as a potential method to improve the quality of diagnosis where a 
specific distribution of brain functional pathology is expected but difficult to detect with 
existing technologies. For example, various types of lesions within the medial temporal 
lobe (MTL) may disrupt memory; however, differences in functional activity across 
different MTL subregions may differentiate older adults who have Alzheimer’s disease 
(AD) pathology from other disorders (e.g., Small, Perera, DeLaPaz, Mayeux, & Stern, 
1999). The risk of misdiagnosis to the patient is significant, but more harmful if the result 
is delay or denial of effective treatment.  
Functional imaging may assist in demonstrating the brain regions being affected by drug 
treatment (e.g., Rombouts, Barkhof, van Meel, & Scheltens, 2002; Sperling et al., 2002), 
functional compensation (e.g., Horwitz et al., 1998; Maguire et al., 2001), and disease 
progression. It is possible that different patterns of brain activation could be associated 
with similar behavior in the present, but different responses to psychological and 
pharmacological treatments. Functional MRI is thus under development as a marker of 
treatment response. Errors could result in denial of effective treatment while appropriate 
use may lead to a more cost effective distribution of limited resources. Some fMRI 
approaches could be applied to define subgroups at-risk for the development of brain 
disease. Clinical trials performed on at-risk subgroups typically require fewer participants 
(due to less intersubject variability of response); however, this limits the generalizability 
to these populations and thus may result in treatment guidelines that restrict access of 
other groups. Ultimately fMRI is an expensive technology and appropriate use must take 
into account the manner in which results complement and augment information already 
available about the function of healthy and impaired brains.  
5. General conclusions 
Functional imaging, if applied responsibly, has great potential to enhance 
neuropsychological assessment and to be a useful component of a comprehensive 
evaluation in certain conditions. Because the technique reveals new information about the 
brain, it is essential to consider its limitations. Perhaps most importantly, current 
implementations of fMRI only have the power to answer a few questions at a time. 
Therefore, fMRI should only be used in a given patient in the context of a broader 
cognitive and clinical evaluation. Competent use of fMRI requires an understanding of 
when imaging applications are appropriate. Furthermore, acquisition, analysis, and 
interpretation of imaging results must be informed by an acute awareness of the technical 
characteristics and limitations of the measure (e.g., Jezzard, Matthews, & Smith, 2002;
Moonen & Bandettini, 1999; Toga & Mazziotta, 2000). There are multiple practical 
hurdles to performing fMRI research. Obtaining informed consent in a cognitively 
impaired population is more complex than in the standard neuropsychological context. In 
addition, the risks to participants are higher than in traditional neuropsychological 
procedures. With careful screening and safety procedures, the long term effects of 
exposure to the magnetic field are believed to be negligible; however, emotional and 
physical responses to the stress of prolonged immobility and confined environment must 
be considered when testing cognitively and emotionally disabled individuals. For now, 
performing competent brain imaging requires intensive time commitment and 
institutional support. In addition, much work is needed before current brain imaging tools 
have the psychometric rigor to be applied to the clinical evaluation of individual patients. 
It is an ethical responsibility for a neuropsychologist involved with fMRI to recognize the 
current state of knowledge and the extent to which it justifies procedures and conclusions 
applied to individuals. The ethical neuropsychologist will resist pressures to make 
premature interpretations, particularly when the audience is not qualified to evaluate their 
factual basis. While these techniques are relatively young, they are rapidly maturing and 
will likely revolutionize the field of clinical neuropsychology by illuminating aspects of 
brain–behavior relationships that were previously inaccessible. The neuropsychologist 
who will enter the field now will be in a position to work at the forefront of an exciting 
new field, which at some point will be recognized as a legitimate subspecialty of 
neuropsychology.  
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